Table 3 of Luensmann, Mol Vis 2010; 16:79-92.
ETAFILCON A |
HEL | BSA | ||||
---|---|---|---|---|---|---|
D1 |
D14 |
Difference between treatments* |
D1 |
D14 |
Difference between treatments* |
|
RINSE (a) | 1139.8±7.14 | 2200.3±15.64 | (b), (c), (d) | 0.16±0.037 | 0.20±0.037 | (b), (c), (d) |
MPS-NO-RUB (b) | 909.3±5.52 | 1852.1±19.16 | (a), (c), (d) | 0.03±0.006 | 0.09±0.005 | (a) |
MPS-RUB (c) | 906.6±13.00 | 1841.5±10.38 | (a), (b) | 0.02±0.004 | 0.08±0.013 | (a) |
H2O2 (d) | 783.4±11.13 | 1666.1±15.83 | (a), (b) | 0.02±0.004 | 0.08±0.041 | (a) |